Disruptive MedTech, LLC

Disruptive MedTech is a contract manufacturing and fulfillment partner specializing in custom, private-branded orthopedic medical devices. Based in Laramie, Wyoming, the company serves hospitals, ambulatory surgery centers (ASCs), private practice clinics, military, and veterans' administration facilities through a direct-to-hospital (D2H) model. DMTI operates as a Group Manufacturing Organization (GMO), offering end-to-end services from product design and development through manufacturing, quality assurance, assembly, testing, and market fulfillment. The company adheres to ISO 13485:2016 standards and maintains FDA compliance, with over 10,000 Mahe-branded products already FDA-approved. Core manufacturing services include contract manufacturing of marrow access and stimulation systems (SmartShot®), orthopedic implant hardware (Xtracta-Screw for Mahe Medical), tray kitting and replenishment (Accufix for Accu-Joint), and design-to-manufacturing support (PanPlasty for PanOrthopedic). Additional services include surgical tray reprocessing with full traceability and stock management, and sterile barrier packaging for medical and biotech products. The company employs statistical process controls and continuous improvement methodologies (6S philosophy) across all operations and expanded production capacity in 2024.